Application of cinnamic acid derivative in mosquito control
By developing and optimizing the active group combination of cinnamic acid derivatives, and using multi-step reaction technology to prepare efficient insecticides, the problems of reducing the effect of existing pesticides and environmental pressure are solved, and low-toxic and highly active mosquito control is achieved Effect.
Patent Information
- Application Number
- CN202211017248.X
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2022-08-23
- Publication Date
- 2024-11-01
- Estimated Expiration
- 2042-08-23
AI Technical Summary
The effect of existing pesticides on mosquito control has gradually decreased, and long-term use has led to increased biotoxicity and environmental pressure, and a low-toxic, low-residual and high-active alternative is needed.
Develop a cinnamic acid derivative, and use aldol condensation, oxidation, condensation and reduction reactions to prepare cinnamic acid derivatives with high insecticidal activity through the combination of different active groups. The relationship between the specific structure and the active groups is optimized. , to improve insecticide effect.
It has achieved efficient killing of mosquitoes at low concentrations, with a larval mortality rate of 78-100%, replacing traditional pesticides, reducing biotoxicity and environmental pressure, and providing an environmentally friendly mosquito control plan.
Smart Images

Figure CN115413657B_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the field of pesticide chemistry, and particularly relates to application of a cinnamic acid derivative in mosquito control. Background Art
[0002] At present, organochlorine, organophosphorus, carbamate and pyrethroid pesticides are mainly used to control mosquitoes. However, due to long-term, large-scale and irrational use, mosquitoes have developed resistance to the four major pesticides, and the resistance level is still rising. In order to achieve the same control effect, the amount of chemical pesticides used is increasing, and the toxicity to non-target organisms and the pressure on the environment are also increasing.
[0003] Cinnamic acid is an organic acid isolated from cinnamon bark or benzoin, and is a natural compound belonging to the phenylpropanoid class. It has good antioxidant, antibacterial, antitumor, and insecticidal properties. Therefore, it is widely used in various fields such as food, beauty, medicine, and pesticides.
[0004] Based on this, it is of great significance to develop a low-toxic, low-residue, highly active, environmentally friendly cinnamic acid derivative by combining cinnamic acid and compounds with different substituents to replace the highly toxic and high-residue pesticides of the past. Summary of the invention
[0005] The purpose of the present invention is to provide an application of a cinnamic acid derivative in mosquito control in view of the deficiencies of the prior art, and to provide a preparation method of the cinnamic acid derivative.
[0006] To achieve the above object, the technical solution adopted by the present invention is: an application of a cinnamic acid derivative in mosquito control, wherein the structural formula of the cinnamic acid derivative is shown in formula (1):
[0007]
[0008] in, Expressed as single or double bonds;
[0009] R1 is any one of H, F, Cl, Br, CF3, CH3, OCH3, NO2, and CN;
[0010] R2 is H or C n H 2n+1 Any one of, n=1-9;
[0011] R3 is any one of the structural formulas (a)-(h), n=1-9, and X is any one of H, F, and Cl;
[0012]
[0013] The cinnamic acid derivatives of the present invention have different active groups. When the cinnamic acid derivatives are applied to insecticide, the insecticidal activity of the cinnamic acid derivatives is closely related to the active groups. The R3 substituent of the cinnamic acid derivative can be an alkane, an alkene or a heterocyclic structure. Through multiple experiments, the inventors found that when the R3 substituent is a straight-chain alkane, the activity of the cinnamic acid derivative is related to the length of the carbon atom of the carbon chain. When the R3 substituent is an alkene, the insecticidal activity is excellent, for example, when the alkene is propylene and butene, the activity is higher. When the R3 substituent is a heterocyclic ring, the insecticidal activity is better when the furan ring is connected, and the activity is relatively poor when the benzene ring is connected. When the benzene ring on the R3 substituent is connected to an electron-withdrawing group or an electron-donating group, the insecticidal activity is deteriorated. At the same time, the chain length of R2 will also affect the insecticidal activity. The longer the chain length, the worse the insecticidal activity. After reducing the double bond, the insecticidal activity decreases, indicating that the double bond plays an important role in the activity of the cinnamic acid derivative. When the cinnamic acid derivatives of the present invention are used to kill mosquitoes, they have insecticidal activity when the concentration of the cinnamic acid derivatives is 20 ppm, and the larval mortality rate can reach up to 78-100%.
[0014] Preferably, the application of the cinnamic acid derivatives includes at least one of the following (i)-(iii):
[0015] (i) wherein R1 is H or Cl in the structural formula of the cinnamic acid derivative;
[0016] (ii) wherein R2 is H or C n H 2n+1 Any one of, n = 1-5;
[0017] (iii) In the structural formula of the cinnamic acid derivative, R3 is any one of the structural formulas (a)-(h), and n=3-5.
[0018] Among the cinnamic acid derivatives of the present invention, when R1 in the structural formula of the cinnamic acid derivative is H and the R3 substituent is a straight-chain alkane, a medium chain length of 3-5 carbon atoms in the carbon chain has good insecticidal activity. At this time, when the concentration of the cinnamic acid derivative is 50 ppm, the larval mortality rate is above 95%. The insecticidal activity of a short chain with less than 3 carbon atoms and a long chain with more than 5 carbon atoms is relatively poor. At the same time, when the carbon chain length of R2 exceeds 5, the insecticidal activity is reduced.
[0019] When R1 in the structural formula of the cinnamic acid derivative is Cl, the insecticidal activity of the cinnamic acid derivative is significantly improved, and when the concentration of the cinnamic acid derivative is 20 ppm, the larval mortality rate is above 98%. This indicates that when Cl atoms are introduced into the benzene ring of the cinnamic acid main body, they can work together with other active groups to improve the insecticidal activity of the cinnamic acid derivative.
[0020] Preferably, the cinnamic acid derivative is used, and the structural formula of the cinnamic acid derivative is any one of formulas (2)-(23):
[0021]
[0022] When the structural formula of the cinnamic acid derivative of the present invention is any one of formulas (2)-(23), when it is used for killing insects, the larval mortality rate reaches more than 95% when the concentration of the cinnamic acid derivative is 50 ppm. When the structural formula of the cinnamic acid derivative is formula (11)-(18), Cl atoms are introduced into the benzene ring, and the cinnamic acid derivative has a lower concentration of mosquito killing effect.
[0023] Preferably, when the cinnamic acid derivative is used, the minimum effective mass concentration of the cinnamic acid derivative when used is 5-20 ppm.
[0024] Preferably, the present invention provides a method for preparing the above-mentioned cinnamic acid derivative, the preparation method comprising the following steps:
[0025] Compound A is used as a raw material, compound A and an aldehyde compound are dissolved in a solvent, and an aldol condensation reaction occurs under the action of an inorganic base to obtain compound B; compound B is dissolved in a solvent, a protective agent, sodium dihydrogen phosphate and sodium chlorite are added, and an oxidation reaction occurs to obtain compound C; a condensation agent, a first catalyst and an organic base are added to compound C in a solvent, and a condensation reaction occurs with an alcohol compound to obtain compound D; a second catalyst is added to compound D in a solvent, and a reduction reaction occurs to obtain compound E; the compound D and the compound E are the cinnamic acid derivatives of formula (1);
[0026] The reduction reaction is carried out under hydrogen conditions;
[0027] The structural formula of the compound A is shown below:
[0028]
[0029] Among them, R1 is any one of H, F, Cl, Br, CF3, CH3, OCH3, NO2, and CN.
[0030] The preparation method of the present invention prepares cinnamic acid derivatives through multiple steps. By controlling the types of raw materials, aldehyde compounds and alcohol compounds, cinnamic acid derivatives with different active groups can be obtained. The prepared cinnamic acid derivatives have the characteristics of low toxicity and high activity. The insecticidal activity of cinnamic acid derivatives is closely related to the R1, R2, and R3 groups. The active groups can interact with each other to affect their insecticidal effects. At the same time, the inventors found that after phenylethyl alcohol, carvacrol, thymol, limonene and other substances with larvicidal activity were esterified with cinnamic acid, the activity of the obtained cinnamic acid derivatives became poor. According to actual needs, those skilled in the art can remove the cinnamic acid derivatives contained in the cinnamic acid derivatives. The conversion can be performed to either retain the double bond or further reduce it to a single bond.
[0031] Preferably, the aldehyde compound has a structural formula of R2-CH2CHO, where R2 is H or C n H 2n+1 any one of the formulas (a) to (h), n=1-9; the alcohol compound has a structural formula of R3-OH, wherein R3 is any one of the structural formulas (a) to (h), n=1-9, and X is any one of H, F, and Cl;
[0032]
[0033] Preferably, the molar ratio of the compound A, the aldehyde compound and the inorganic base is 1: (0.5-1): (20-90); the molar ratio of the compound B, the protective agent, sodium dihydrogen phosphate and sodium chlorite is 1: (10-20): (3-5): (1-3); the molar ratio of the compound C, the alcohol compound, the condensation agent, the first catalyst and the organic base is 1: (1-2): (1.2-3): (1.2-3): (3-5); the molar ratio of the compound D and the second catalyst is 1: (0.1-0.3).
[0034] Preferably, the solvent is any one of ethanol, tetrahydrofuran, dichloromethane and methanol; the inorganic base is any one of sodium hydroxide and potassium hydroxide; and the organic base is triethylamine.
[0035] Preferably, the protective agent is 2-dimethyl-2-butene; the condensing agent is any one of 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride and benzotriazole-1-yl-oxytripyrrolidinophosphine hexafluorophosphate; the first catalyst is any one of 1-hydroxybenzotriazole and p-dimethylaminopyridine; and the second catalyst is palladium on carbon.
[0036] Compared with the prior art, the present invention has the following beneficial effects:
[0037] (1) The present invention provides an application of a cinnamic acid derivative in mosquito control. When the cinnamic acid derivative is applied to mosquito control, the cinnamic acid derivative has insecticidal activity at a concentration of 20 ppm. The cinnamic acid derivative can replace traditional pesticides for mosquito killing, avoiding the problems of biological toxicity and environmental pressure caused by the use of traditional pesticides.
[0038] (2) The present invention provides a method for preparing the cinnamic acid derivatives. The method can be used to prepare cinnamic acid derivatives with different active groups. The prepared cinnamic acid derivatives have the characteristics of low toxicity and high activity. The insecticidal activity of the cinnamic acid derivatives is closely related to the active groups introduced. When Cl atoms are introduced into the main benzene ring in the structural formula of the cinnamic acid derivatives of the present invention, they are used for insecticide. When the concentration of the cinnamic acid derivatives is 20 ppm, the larval mortality rate reaches more than 98%. BRIEF DESCRIPTION OF THE DRAWINGS
[0039] Figure 1 This is the hydrogen nuclear magnetic resonance spectrum of product 7D in Example 7 of the present invention.
[0040] Figure 2 This is the hydrogen nuclear magnetic resonance spectrum of product 14D in Example 14 of the present invention.
[0041] Figure 3 The hydrogen nuclear magnetic resonance spectrum of the product 20D in Example 20 of the present invention is
[0042] Figure 4 This is the hydrogen nuclear magnetic resonance spectrum of product 21D in Example 21 of the present invention. DETAILED DESCRIPTION
[0043] In order to better illustrate the purpose, technical solutions and advantages of the present invention, the present invention will be further described below in conjunction with specific embodiments, but the protection scope and implementation methods of the present invention are not limited thereto.
[0044] Unless otherwise specified, the experimental methods used in the following examples are all conventional methods; the materials and reagents used are reagents and materials that can be obtained from commercial channels unless otherwise specified.
[0045] Example 1
[0046] The synthetic route of a cinnamic acid derivative is as follows:
[0047]
[0048] The preparation method of the cinnamic acid derivative (product 1D) of this embodiment comprises the following steps:
[0049] Under ice bath conditions, anhydrous ethanol was added to 12 mmol of benzaldehyde (raw material 1A), and then 10 mmol of acetaldehyde was added, and then 1 M sodium hydroxide aqueous solution was added dropwise, and stirred overnight at room temperature. After the reaction was completed, distilled water and saturated brine were used for extraction, and then the organic phase was separated and purified by column chromatography to obtain compound 2B.
[0050] 1 mmol of compound 2B was dissolved in tetrahydrofuran, and then 15 mmol of 2-methyl-2-butene was added under ice bath conditions, and then 4 mmol of sodium dihydrogen phosphate aqueous solution was added, and then 2 mmol of sodium chlorite aqueous solution was added dropwise, and the reaction solution changed from colorless to brown-yellow. The reaction was stirred at room temperature for 5 hours, and the reaction solution changed from brown-yellow to colorless. The reaction solution was adjusted to pH 9-10 with 1 M sodium hydroxide, and extracted with water and saturated brine in sequence to obtain an aqueous phase, and then the aqueous phase was adjusted to pH 3-4 with 1 M hydrochloric acid, and the aqueous phase was extracted with ethyl acetate to finally obtain compound 3C.
[0051] 2 mmol of compound 3C was dissolved in dried dichloromethane, 4 mmol of 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (EDCI) was added under ice bath conditions, and then 4 mmol of 1-hydroxybenzotriazole (HOBT) was added. After reacting for 10 minutes, 2.2 mmol of methanol was added, and the pH of the reaction solution was adjusted to 9-10 with triethylamine. The reaction was stirred at room temperature overnight. After the reaction was completed, the product was extracted with water and saturated brine in turn, and finally separated by column chromatography to obtain product 1D.
[0052] Example 2
[0053] The structural formula of the cinnamic acid derivative of this embodiment is as follows:
[0054]
[0055] The preparation method of the cinnamic acid derivative (product 2D) of this embodiment comprises the following steps:
[0056] The same preparation method as in Example 1 was used, except that methanol was replaced by n-propanol to obtain product 2D.
[0057] Example 3
[0058] The structural formula of the cinnamic acid derivative of this embodiment is as follows:
[0059]
[0060] The preparation method of the cinnamic acid derivative (product 3D) of this embodiment comprises the following steps:
[0061] The same preparation method as in Example 1 was used, except that methanol was replaced by allyl alcohol to obtain product 3D.
[0062] Example 4
[0063] The synthetic route of a cinnamic acid derivative is as follows:
[0064]
[0065] The preparation method of the cinnamic acid derivative (product 3E) of this embodiment comprises the following steps:
[0066] Compound 3D was prepared by the same preparation method as in Example 3. 0.2 mmol of 10% palladium carbon was added to a round-bottom flask, the gas was replaced with nitrogen three times, and then replaced with hydrogen three times, and then a hydrogen balloon was inserted, methanol was introduced as a solvent, and 2 mmol of compound 3D was added and stirred at room temperature for 3 hours. After the reaction was completed, the product 3E was obtained by vacuum filtration and column chromatography separation.
[0067] Example 5
[0068] The structural formula of the cinnamic acid derivative of this embodiment is as follows:
[0069]
[0070] The preparation method of the cinnamic acid derivative (product 5D) of this embodiment comprises the following steps:
[0071] The same preparation method as in Example 1 was used, except that methanol was replaced by isopropanol to obtain product 5D.
[0072] Example 6
[0073] The structural formula of the cinnamic acid derivative of this embodiment is as follows:
[0074]
[0075] The preparation method of the cinnamic acid derivative (product 6D) of this embodiment comprises the following steps:
[0076] The same preparation method as in Example 1 was used, except that methanol was replaced by n-butanol to obtain product 6D.
[0077] Example 7
[0078] The structural formula of the cinnamic acid derivative of this embodiment is as follows:
[0079]
[0080] The preparation method of the cinnamic acid derivative (product 7D) of this embodiment comprises the following steps:
[0081] The same preparation method as in Example 1 was used, except that methanol was replaced by butenol to obtain product 7D. The product was characterized by NMR. Figure 1shown.
[0082] Example 8
[0083] The structural formula of the cinnamic acid derivative of this embodiment is as follows:
[0084]
[0085] The preparation method of the cinnamic acid derivative (product 8D) of this embodiment comprises the following steps:
[0086] The same preparation method as in Example 1 was used, except that methanol was replaced with 3-hydroxy-1-pentene to obtain product 8D.
[0087] Example 9
[0088] The structural formula of the cinnamic acid derivative of this embodiment is as follows:
[0089]
[0090] The preparation method of the cinnamic acid derivative (product 9D) of this embodiment comprises the following steps:
[0091] The same preparation method as in Example 1 was used, except that methanol was replaced with 2,4-hexadien-6-ol to obtain product 9D.
[0092] Example 10
[0093] The structural formula of the cinnamic acid derivative of this embodiment is as follows:
[0094]
[0095] The preparation method of the cinnamic acid derivative (product 10D) of this embodiment comprises the following steps:
[0096] The same preparation method as in Example 1 was used, except that methanol was replaced with n-pentanol to obtain product 10D.
[0097] Embodiment 11
[0098] The structural formula of the cinnamic acid derivative of this embodiment is as follows:
[0099]
[0100] The preparation method of the cinnamic acid derivative (product 11D) of this embodiment comprises the following steps:
[0101] The same preparation method as in Example 1 was used, except that methanol was replaced by benzyl alcohol to obtain product 11D.
[0102] Example 12
[0103] The structural formula of the cinnamic acid derivative of this embodiment is as follows:
[0104]
[0105] The preparation method of the cinnamic acid derivative (product 12D) of this embodiment comprises the following steps:
[0106] The same preparation method as in Example 1 was used, except that methanol was replaced by p-fluorobenzyl alcohol to obtain product 12D.
[0107] Example 13
[0108] The structural formula of the cinnamic acid derivative of this embodiment is as follows:
[0109]
[0110] The preparation method of the cinnamic acid derivative (product 13D) of this example comprises the following steps:
[0111] The same preparation method as in Example 1 was used, except that methanol was replaced by p-chlorobenzyl alcohol to obtain product 13D.
[0112] Embodiment 14
[0113] The structural formula of the cinnamic acid derivative of this embodiment is as follows:
[0114]
[0115] The preparation method of the cinnamic acid derivative (product 14D) of this example comprises the following steps:
[0116] The same preparation method as in Example 1 was used, except that methanol was replaced by furan benzyl alcohol to obtain product 14D. The product was characterized by NMR. Figure 2 shown.
[0117] Embodiment 15
[0118] The structural synthesis route of the cinnamic acid derivative of this embodiment is as follows:
[0119]
[0120] The preparation method of the cinnamic acid derivative (product 15D) of this example comprises the following steps:
[0121] The same preparation method as in Example 3 was used, except that acetaldehyde was replaced by propionaldehyde to obtain product 15D.
[0122] Example 16
[0123] The structural formula of the cinnamic acid derivative of this embodiment is as follows:
[0124]
[0125] The preparation method of the cinnamic acid derivative (product 16D) of this example comprises the following steps:
[0126] The same preparation method as in Example 3 was used, except that the original acetaldehyde was replaced by n-valeraldehyde to obtain product 16D.
[0127] Embodiment 17
[0128] The structural formula of the cinnamic acid derivative of this embodiment is as follows:
[0129]
[0130] The preparation method of the cinnamic acid derivative (product 17D) of this example comprises the following steps:
[0131] The same preparation method as in Example 3 was used, except that acetaldehyde was replaced by n-heptanal to obtain product 17D.
[0132] Embodiment 18
[0133] The structural formula of the cinnamic acid derivative of this embodiment is as follows:
[0134]
[0135] The preparation method of the cinnamic acid derivative (product 18D) of this example comprises the following steps:
[0136] The same preparation method as in Example 3 was used, except that the raw material benzaldehyde was replaced with o-chlorobenzaldehyde to obtain product 18D.
[0137] Embodiment 19
[0138] The structural formula of the cinnamic acid derivative of this embodiment is as follows:
[0139]
[0140] The preparation method of the cinnamic acid derivative (product 19D) of this example comprises the following steps:
[0141] The same preparation method as in Example 3 was used, except that the raw material benzaldehyde was replaced with m-chlorobenzaldehyde to obtain product 19D.
[0142] Embodiment 20
[0143] The structural formula of the cinnamic acid derivative of this embodiment is as follows:
[0144]
[0145] The preparation method of the cinnamic acid derivative (product 20D) of this embodiment comprises the following steps:
[0146] The same preparation method as in Example 3 was used, except that the raw material benzaldehyde was replaced with p-chlorobenzaldehyde to obtain product 20D. The product was characterized by NMR. Figure 3 shown.
[0147] Embodiment 21
[0148] The structural formula of the cinnamic acid derivative of this embodiment is as follows:
[0149]
[0150] The preparation method of the cinnamic acid derivative (product 21D) of this embodiment comprises the following steps:
[0151] The same preparation method as in Example 20 was used, except that propylene was replaced with butenol to obtain product 21D. The product was characterized by NMR. Figure 4 shown.
[0152] Embodiment 22
[0153] The structural formula of the cinnamic acid derivative of this embodiment is as follows:
[0154]
[0155] The preparation method of the cinnamic acid derivative (product 22D) of this embodiment comprises the following steps:
[0156] The same preparation method as in Example 20 was used, except that propylene alcohol was replaced by ethanol to obtain product 22D.
[0157] Embodiment 23
[0158] The structural formula of the cinnamic acid derivative of this embodiment is as follows:
[0159]
[0160] The preparation method of the cinnamic acid derivative (product 23D) of this embodiment comprises the following steps:
[0161] The same preparation method as in Example 20 was used, except that propenol was replaced with n-propanol to obtain product 23D.
[0162] Embodiment 24
[0163] The structural formula of the cinnamic acid derivative of this embodiment is as follows:
[0164]
[0165] The preparation method of the cinnamic acid derivative (product 24D) of this embodiment comprises the following steps:
[0166] The same preparation method as in Example 20 was used, except that propenol was replaced with isopropanol to obtain product 24D.
[0167] Embodiment 25
[0168] The structural formula of the cinnamic acid derivative of this embodiment is as follows:
[0169]
[0170] The preparation method of the cinnamic acid derivative (product 25D) of this example comprises the following steps:
[0171] The same preparation method as in Example 20 was used, except that propenol was replaced with n-butanol to obtain product 25D.
[0172] Comparative Example 1
[0173] The structural formula of the cinnamic acid of this comparative example is as follows:
[0174]
[0175] The preparation method of cinnamic acid in this comparative example comprises the following steps:
[0176] The same preparation method as in Example 1 was used to obtain compound 3C, which is the product of this comparative example.
[0177] Comparative Example 2
[0178] The structural formula of the cinnamic acid derivative of this comparative example is as follows:
[0179]
[0180] The preparation method of the cinnamic acid derivative of this comparative example comprises the following steps:
[0181] The product was obtained by using the same preparation method as in Example 1, except that methanol was replaced by nerol.
[0182] Comparative Example 3
[0183] The structural formula of the cinnamic acid derivative of this comparative example is as follows:
[0184]
[0185] The preparation method of the cinnamic acid derivative of this comparative example comprises the following steps:
[0186] The product was obtained by the same preparation method as in Example 1, except that methanol was replaced by p-bromobenzyl alcohol.
[0187] Comparative Example 4
[0188] The structural formula of the cinnamic acid derivative of this comparative example is as follows:
[0189]
[0190] The preparation method of the cinnamic acid derivative of this comparative example comprises the following steps:
[0191] The product was obtained by the same preparation method as in Example 1, except that methanol was replaced by carvacrol.
[0192] Comparative Example 5
[0193] The structural formula of the cinnamic acid derivative of this comparative example is as follows:
[0194]
[0195] The preparation method of the cinnamic acid derivative of this comparative example comprises the following steps:
[0196] The same preparation method as in Example 1 was used, except that methanol was replaced by thymol to obtain the product.
[0197] Comparative Example 6
[0198] The structural formula of the cinnamic acid derivative of this comparative example is as follows:
[0199]
[0200] The preparation method of the cinnamic acid derivative of this comparative example comprises the following steps:
[0201] The same preparation method as in Example 1 was used, except that methanol was replaced by limonenol to obtain the product.
[0202] Comparative Example 7
[0203] The structural formula of the cinnamic acid derivative of this comparative example is as follows:
[0204]
[0205] The preparation method of the cinnamic acid derivative of this comparative example comprises the following steps:
[0206] The same preparation method as in Example 1 was used, except that methanol was replaced by 3-pyridine benzyl alcohol to obtain the product.
[0207] Effect Example 1
[0208] The insecticidal activity tests were performed on the cinnamic acid derivatives prepared in all the examples and comparative examples.
[0209] According to the larval dipping method recommended by WHO, insecticidal tests were conducted on the IV-instar larvae of the sensitive strain of Aedes albopictus reared in the laboratory.
[0210] Experimental method: First, acetone was used as solvent, and different cinnamic acid derivatives were prepared as samples to be tested. Sample solutions of a certain concentration were prepared, and then 1 mL of the sample solution was added to 99 mL of distilled water, which was the test solution. The test solutions with concentrations of 20 ppm and 50 ppm were tested for insecticidal activity. The blank group was the acetone solvent group without cinnamic acid, and the positive drug deltamethrin was used as the control group. 20 healthy, normal-sized, instar 4 larvae of Aedes albopictus were transferred into a group and placed in the test solution. Then, they were placed in a constant temperature and humidity chamber (28°C ± 1°C, 75% ± 5%) for 24 hours. No food was given during the culture period, and each concentration was repeated 3 times. After 24 hours, the number of larval deaths was observed. The larvae were gently touched with the tip of a clean pipette. If there was no physiological activity, they were considered dead. The formula for calculating the corrected mortality rate of larvae is: Corrected mortality rate (%) = (mortality rate of the test group - mortality rate of the blank group) / (1-mortality rate of the blank group). The insecticidal activity results are shown in Table 1 and Table 2, where LC 50 (ppm) indicates the concentration of cinnamic acid derivatives when the larval mortality rate is 50%, LC 90 (ppm) indicates the concentration of cinnamic acid derivatives when the larval mortality rate is 90%.
[0211] Table 1 Test results of insecticidal activity of Examples 1-25
[0212]
[0213] Table 2 Test results of insecticidal activity of comparative examples 1-7
[0214]
[0215] As shown in Table 1 and Table 2, the cinnamic acid derivatives prepared in Examples 1-25 of the present application have certain insecticidal activity against the IV-stage larvae of the sensitive Aedes albopictus at a concentration of 20 ppm. When the concentration is 20 ppm, the larval mortality rate is as low as 1.7% and as high as 78-100%. When the concentration is 50 ppm, the larval mortality rate is above 75%, and most of the cinnamic acid derivatives have an insecticidal mortality rate of 95-100%. As shown in Examples 1, 2, 6, and 10, when the cinnamic acid derivatives are connected to straight-chain alkanes, they have good insecticidal activity, and the carbon chain has 3-5 carbon atoms. The larval mortality rate of the cinnamic acid derivatives at a concentration of 50 ppm is above 95%, and the insecticidal activity decreases when the carbon atoms are less than 3 short chains and greater than 5 long chains. As shown in Examples 3, 7, and 9, when the cinnamic acid derivatives are connected to olefins, they have excellent insecticidal activity, and the insecticidal activity is better when they are connected to propylene and butene. From Examples 11-14, it can be seen that when the cinnamic acid derivatives are connected to heterocyclic rings, the best insecticidal activity is when connected to the furan ring, followed by the benzene ring. From Examples 12-13, it can be seen that when the benzene ring is connected to an electron-withdrawing group at the para position, the activity decreases. From Examples 3 and 4, it can be seen that when the double bond is reduced, the insecticidal activity decreases at low concentrations, indicating that the double bond plays an important role in the activity of cinnamic acid derivatives. From Examples 18-25, it can be seen that when Cl atoms are introduced into the benzene ring of the cinnamic acid main body, LC 50 (ppm) and LC 90 (ppm) is lower, and the insecticidal activity is significantly improved. It can be seen from Examples 15-17 that as the chain length of R2 increases, the insecticidal activity of cinnamic acid derivatives at low concentrations decreases. It can be seen from Examples 2-11 and Examples 14-25 that the larval mortality rate when the concentration of cinnamic acid derivatives is 50ppm is all above 95%. It can be seen from Table 2 that under the same test conditions, when the cinnamic acid concentration of Comparative Example 1 is 20ppm and 50ppm, the insecticidal activity is 0. It can be seen from Comparative Examples 2-7 that when the inserted active group is not within the scope of this application, when the concentration of cinnamic acid derivatives is 20ppm, the larval mortality rate is 0, and it has no insecticidal activity. When the concentration is 50ppm, the insecticidal activity of cinnamic acid derivatives is very low.
[0216] Effect Example 2
[0217] Larvicidal activity test of cinnamic acid derivatives at different concentration gradients.
[0218] Experimental method: Acetone is used as solvent, and the cinnamic acid derivatives prepared in Example 3, Example 4, and Examples 18-25 are used as test samples. A sample solution of a certain concentration is prepared, and then 1 mL of the sample solution is added to 99 mL of distilled water, which is the test solution. The concentration of the cinnamic acid derivative in the test solution is between 0 ppm and 30 ppm. The insecticidal activity of the cinnamic acid derivative under different concentration gradients is tested. The blank group is an acetone solvent group with a test solution concentration of 0 ppm. 20 healthy, normal-sized, Aedes albopictus larvae in the fourth instar are transferred as a group, placed in the test solution, and then placed in a constant temperature and humidity chamber (28°C ± 1°C, 75% ± 5%) for 24 hours. No food is given during the culture period, and each concentration is repeated 3 times. After 24 hours, the number of larval deaths is observed, and the larvae are gently touched with a clean pipette tip. If there is no physiological activity, it is considered dead. The formula for calculating the corrected mortality rate of larvae is: Corrected mortality rate (%) = (test group mortality rate - blank group mortality rate) / (1-blank group mortality rate). The insecticidal activity results are shown in Table 3-12.
[0219] Table 3 Test results of insecticidal activity of Example 3
[0220]
[0221] Table 4 Test results of insecticidal activity of Example 4
[0222]
[0223] Table 5 Test results of insecticidal activity of Example 18
[0224]
[0225]
[0226] Table 6 Test results of insecticidal activity of Example 19
[0227]
[0228] Table 7 Test results of insecticidal activity of Example 20
[0229]
[0230] Table 8 Test results of insecticidal activity of Example 21
[0231]
[0232] Table 9 Test results of insecticidal activity of Example 22
[0233]
[0234] Table 10 Test results of insecticidal activity of Example 23
[0235]
[0236]
[0237] Table 11 Test results of insecticidal activity of Example 24
[0238]
[0239] Table 12 Test results of insecticidal activity of Example 25
[0240]
[0241] As shown in Tables 3-4, the cinnamic acid derivatives prepared in Examples 3 and 4 can effectively kill the 4th instar larvae of Aedes albopictus at a concentration of 30 ppm, and are dose-dependent. As shown in Tables 5-12, when the cinnamic acid derivatives introduce Cl atoms on the main benzene ring, the concentration of the cinnamic acid derivatives required to kill the larvae is lower.
[0242] Finally, it should be noted that the above embodiments are only used to illustrate the technical solutions of the present invention, rather than to limit the protection scope of the present invention. For those skilled in the art, other different forms of changes or modifications can be made based on the above descriptions and ideas. It is not necessary and impossible to list all the implementation methods here. Any modifications, equivalent substitutions and improvements made within the spirit and principles of the present invention should be included in the protection scope of the claims of the present invention.
Claims
1. Use of a cinnamic acid derivative in mosquito control, characterized in that: The structural formula of the cinnamic acid derivative is shown in formula (1): in, Expressed as single or double bonds; R1 is any one of H, F, Cl, and Br; R2 is H or C n H 2n+1 Any one of, n = 1-5; R3 is any one of the structural formulas (d), (e), (f), and (h); 2. The use according to claim 1, characterized in that The structural formula of the cinnamic acid derivative is any one of formulas (3) to (14):
3. The use according to claim 1, characterized in that The minimum effective mass concentration of the cinnamic acid derivative when used is 5-20 ppm.
